Can a simple warfarin initiation scheme predict the maintenance dose in patients with nonrheumatic atrial fibrillation?
Culhane
Nicole S
NS
Wilkes University, Nesbitt School of Pharmacy, Wyoming Valley Family Practice Center, Wilkes-Barre, PA, USA. sparano@wilkes.edu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D006801:Humans; D019934:International Normalized Ratio; D008875:Middle Aged; D014859:Warfarin / Q000008:administration & dosage* / Q000494:pharmacology
D000925:Anticoagulants; D014859:Warfarin